BioSpace News Archive

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced its third quarter 2021 financial results and provided a business update and outlook for the remainder of the year.

The global market for therapeutic vaccines is witnessing a phase of significant growth. Thanks to the efficiency of these vaccines, an upsurge in their demand is likely to continue over the next few years.

Telemedicine can be defined as the process of providing healthcare services through technology, primarily through the usage of videoconferencing.

Syngenta Group announced strong sales growth for the third quarter and the first nine months ending on September 30, 2021.

Personalized therapy is related to the genetic makeup of a person. It helps doctors to understand how a tumor grows in a particular patient to identify effective screening, control, and treatment methods.

Of late, the global musculoskeletal diseases market has been witnessing a tremendous rise in its size as well as valuation.

West Pharmaceutical Services, Inc. announced its financial results for the third-quarter 2021 and updated full-year 2021 financial guidance.

CB Scientific, Inc. is a provider of remote ECG cardiac monitoring products and services; simple wearable solutions for detecting potentially life-threatening heart arrhythmias in patients with heart-related issues, both domestically and internationally.

Centogene N.V., a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced that the first patient has been enrolled in the international EFRONT Study, an observational study to understand the prevalence of genetic mutations in patients with frontotemporal dementia.

Novocure announced that the final patient has been enrolled in phase 3 pivotal INNOVATE-3 trial evaluating the efficacy of Tumor Treating Fields together with paclitaxel for treatment of patients with platinum-resistant ovarian cancer.